REQUEST A DEMO
Total
USD $0.00
Search more companies

Mylan Healthcare Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Mylan Healthcare Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Trading of medical devices and provision of marketing services in pharmaceutical products, medical devices, food supplements, cosmetics and health and nutritional products.

Headquarters
15-03 & 14-04, Level 15, Imazium, No. 8, Jalan Ss 21/37, Damansara Uptown
Petaling Jaya; Selangor; Postal Code: 47400

Contact Details: Purchase the Mylan Healthcare Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Mylan Healthcare Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Mylan Healthcare Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Mylan Healthcare Sdn. Bhd. report to view the information.
Incorporation Date:
October 09, 2015
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Mylan Healthcare Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
166.86%
Total operating revenue
166.86%
Operating profit (EBIT)
284.67%
EBITDA
250.44%
Net Profit (Loss) for the Period
296.07%
Total assets
172.28%
Total equity
59.88%
Operating Profit Margin (ROS)
2.14%
Net Profit Margin
1.36%
Return on Equity (ROE)
22.33%
Quick Ratio
-0.16%
Cash Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?